Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
Diabetes mellitus is a group of a metabolic disorder caused when the body is unable to produce required quantity of Insulin. Insulin is a hormone secreted by beta cells of the islet of Langerhans of the pancreas. Various symptoms associated with diabetes disorder include recurrent urination, increased thirst, and hunger. Diabetes can cause much chronic complication if left untreated. Some of them include acute complications like diabetic ketoacidosis, chronic kidney failure, foot ulcers, and damage to the eyes.
Oral antidiabetic drugs have the advantages of convenience, quickness, and easy access, and are being accepted by patients. Manufacturers of oral antidiabetic drugs are also developing to produce drugs with better effects, and the global oral hypoglycemic drug market will continue to grow.
The global growth of the oral antidiabetic drug market is mainly due to the increased prevalence of diabetic patients worldwide. This growth has continued to occur in developing countries such as India and China. Also, factors leading to an increase in the global diabetes population include sedentary lifestyles, obesity, an increase in the elderly population, and lagging healthcare services. However, the high cost of the drug is expected to limit the growth of the global oral antidiabetic market. The increase in the number of pharmaceutical companies and the emergence of advanced technologies are the key factors driving the growth of this market.
The report details the trend, potential and market size of Oral Antidiabetic Drugs market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.
The first part (Chapter1-7) mainly covers the qualitative analysis of Oral Antidiabetic Drugsmarket, defines the market attractiveness level of Oral Antidiabetic Drugs market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.
The second part (Chapter8-12), based on the segmentation of Oral Antidiabetic Drugs industry, describes the types of Oral Antidiabetic Drugs market, the applications of major players and the market size, and deeply analyzes the current situation of the global Oral Antidiabetic Drugs market and the development prospects and opportunities of Oral Antidiabetic Drugs industry.
The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.
As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global Oral Antidiabetic Drugs market in Chapter 13.
By Player:
Merck
Novartis
Eli Lilly
Sunpharma
Novo Nordisk
Biocon
Pfizer
Abbott
Sanofi
By Type:
Sulfonylureas
Meglitinides
Alpha-glucosidase inhibitors
By End-User:
Hospitals
Clinics
Others
By Geography:
-
United States
-
Europe
-
China
-
Japan
-
India
-
South Korea
TABLE OF CONTENT
1 Introduction
-
1.1 Market Definition
-
1.2 Market Segment Analysis
-
1.3 Market Size 2022
-
1.4 Oral Antidiabetic Drugs Market Outlook: Forecast for 2022 - 2028
-
1.5 Pricing Analysis
2 Executive Summary
3 Oral Antidiabetic Drugs Market Lineage Outlook
-
3.1 Parent Market Outlook
-
3.2 Related/Ancillary Market Outlook
-
3.3 Penetration & Growth Prospect Mapping, 2022
4 Market Analysis Tools: Porter's Five Forces
-
4.1 Supplier Power
-
4.2 Buyer Power
-
4.3 Substitution Threat
-
4.4 Threat of New Entrants
-
4.5 Competitive Rivalry
5 Oral Antidiabetic Drugs Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)
-
5.1 Political/Legal Landscape
-
5.2 Economic Landscape
-
5.3 Social Landscape
-
5.4 Technology Landscape
6 Oral Antidiabetic Drugs Market - Value Chain Analysis
-
6.1 Industry's Value Chain Analysis
-
6.2 Product Life Cycle
-
6.3 User Perspective Analysis
7 Region and Country-wise Oral Antidiabetic Drugs Market Analysis and Outlook to 2022
-
7.1 Global Oral Antidiabetic Drugs Consumption (2017-2022)
-
7.2 United States Oral Antidiabetic Drugs Consumption (2017-2022)
-
7.3 Europe Oral Antidiabetic Drugs Consumption (2017-2022)
-
7.4 China Oral Antidiabetic Drugs Consumption (2017-2022)
-
7.5 Japan Oral Antidiabetic Drugs Consumption (2017-2022)
-
7.6 India Oral Antidiabetic Drugs Consumption (2017-2022)
-
7.7 South Korea Oral Antidiabetic Drugs Consumption (2017-2022)
8 Region and Country-wise Oral Antidiabetic Drugs Market Analysis and Outlook to 2028
-
8.1 Global Oral Antidiabetic Drugs Consumption Forecast (2022-2028)
-
8.2 United States Oral Antidiabetic Drugs Consumption Forecast (2022-2028)
-
8.3 Europe Oral Antidiabetic Drugs Consumption Forecast (2022-2028)
-
8.4 China Oral Antidiabetic Drugs Consumption Forecast (2022-2028)
-
8.5 Japan Oral Antidiabetic Drugs Consumption Forecast (2022-2028)
-
8.6 India Oral Antidiabetic Drugs Consumption Forecast (2022-2028)
-
8.7 South Korea Oral Antidiabetic Drugs Consumption Forecast (2022-2028)
9 Global Oral Antidiabetic Drugs Market Outlook by Types and Applications to 2022
-
9.1 Global Oral Antidiabetic Drugs Consumption and Growth Rate by Type (2017-2022)
-
9.1.1 Global Sulfonylureas Consumption and Growth Rate (2017-2022)
-
9.1.2 Global Meglitinides Consumption and Growth Rate (2017-2022)
-
9.1.3 Global Alpha-glucosidase inhibitors Consumption and Growth Rate (2017-2022)
-
9.2 Global Oral Antidiabetic Drugs Consumption and Growth Rate by Application (2017-2022)
-
9.2.1 Global Hospitals Consumption and Growth Rate (2017-2022)
-
9.2.2 Global Clinics Consumption and Growth Rate (2017-2022)
-
9.2.3 Global Others Consumption and Growth Rate (2017-2022)
10 Global Oral Antidiabetic Drugs Market Outlook by Types and Applications to 2028
-
10.1 Global Oral Antidiabetic Drugs Consumption Forecast and Growth Rate by Type (2022-2028)
-
10.1.1 Global Sulfonylureas Consumption Forecast and Growth Rate (2022-2028)
-
10.1.2 Global Meglitinides Consumption Forecast and Growth Rate (2022-2028)
-
10.1.3 Global Alpha-glucosidase inhibitors Consumption Forecast and Growth Rate (2022-2028)
-
10.2 Global Oral Antidiabetic Drugs Consumption Forecast and Growth Rate by Application (2022-2028)
-
10.2.1 Global Hospitals Consumption Forecast and Growth Rate (2022-2028)
-
10.2.2 Global Clinics Consumption Forecast and Growth Rate (2022-2028)
-
10.2.3 Global Others Consumption Forecast and Growth Rate (2022-2028)
11 Global Oral Antidiabetic Drugs Import and Export Analysis (Top 5 Countries)
-
11.1 Global Oral Antidiabetic Drugs Import by Region (Top 5 Countries) (2017-2028)
-
11.2 Global Oral Antidiabetic Drugs Export by Region (Top 5 Countries) (2017-2028)
12 Coronavirus Disease (COVID-19) Impact
-
12.1 Industry Impact Analysis
-
12.2 Oral Antidiabetic Drugs Market Outlook to 2028 - COVID-19 Affected Forecasts
13 Competition Matrix
-
13.1 Target Markets
-
13.2 Comprehensive Analysis of Products in Competitive Markets
14 Global Oral Antidiabetic Drugs Market Competitive Analysis
-
14.1 Merck
-
14.1.1 Merck Company Details
-
14.1.2 Merck Oral Antidiabetic Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.1.3 Merck Oral Antidiabetic Drugs Product and Service
-
14.2 Novartis
-
14.2.1 Novartis Company Details
-
14.2.2 Novartis Oral Antidiabetic Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.2.3 Novartis Oral Antidiabetic Drugs Product and Service
-
14.3 Eli Lilly
-
14.3.1 Eli Lilly Company Details
-
14.3.2 Eli Lilly Oral Antidiabetic Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.3.3 Eli Lilly Oral Antidiabetic Drugs Product and Service
-
14.4 Sunpharma
-
14.4.1 Sunpharma Company Details
-
14.4.2 Sunpharma Oral Antidiabetic Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.4.3 Sunpharma Oral Antidiabetic Drugs Product and Service
-
14.5 Novo Nordisk
-
14.5.1 Novo Nordisk Company Details
-
14.5.2 Novo Nordisk Oral Antidiabetic Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.5.3 Novo Nordisk Oral Antidiabetic Drugs Product and Service
-
14.6 Biocon
-
14.6.1 Biocon Company Details
-
14.6.2 Biocon Oral Antidiabetic Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.6.3 Biocon Oral Antidiabetic Drugs Product and Service
-
14.7 Pfizer
-
14.7.1 Pfizer Company Details
-
14.7.2 Pfizer Oral Antidiabetic Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.7.3 Pfizer Oral Antidiabetic Drugs Product and Service
-
14.8 Abbott
-
14.8.1 Abbott Company Details
-
14.8.2 Abbott Oral Antidiabetic Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.8.3 Abbott Oral Antidiabetic Drugs Product and Service
-
14.9 Sanofi
-
14.9.1 Sanofi Company Details
-
14.9.2 Sanofi Oral Antidiabetic Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.9.3 Sanofi Oral Antidiabetic Drugs Product and Service
15 Appendix
TABLE OF CHARTS
-
Table Definition of Oral Antidiabetic Drugs
-
Figure Oral Antidiabetic Drugs Picture
-
Table Global Oral Antidiabetic Drugs Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Oral Antidiabetic Drugs Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Oral Antidiabetic Drugs Market: Year-over-year Growth 2022 - 2028 (%)
-
Table Parent Market Analysis
-
Figure Parent Market Price
-
Table Related/Ancillary Market Outlook Analysis
-
Table Supplier Power Analysis
-
Table Buyer Power Analysis
-
Table Substitution Threat Analysis
-
Table Threat of New Entrants Analysis
-
Table Competitive Rivalry Analysis
-
Figure Global Oral Antidiabetic Drugs Consumption by Country (2017-2022)
-
Figure United States Oral Antidiabetic Drugs Consumption and Growth Rate (2017-2022)
-
Table Europe Oral Antidiabetic Drugs Consumption and Growth Rate (2017-2022)
-
Figure China Oral Antidiabetic Drugs Consumption and Growth Rate (2017-2022)
-
Figure Japan Oral Antidiabetic Drugs Consumption and Growth Rate (2017-2022)
-
Figure India Oral Antidiabetic Drugs Consumption and Growth Rate (2017-2022)
-
Figure South Korea Oral Antidiabetic Drugs Consumption and Growth Rate (2017-2022)
-
Figure Global Oral Antidiabetic Drugs Consumption Forecast by Country (2022-2028)
-
Figure United States Oral Antidiabetic Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Table Europe Oral Antidiabetic Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure China Oral Antidiabetic Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure Japan Oral Antidiabetic Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure India Oral Antidiabetic Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure South Korea Oral Antidiabetic Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Sulfonylureas Consumption and Growth Rate (2017-2022)
-
Figure Global Meglitinides Consumption and Growth Rate (2017-2022)
-
Figure Global Alpha-glucosidase inhibitors Consumption and Growth Rate (2017-2022)
-
Figure Global Hospitals Consumption and Growth Rate (2017-2022)
-
Figure Global Clinics Consumption and Growth Rate (2017-2022)
-
Figure Global Others Consumption and Growth Rate (2017-2022)
-
Figure Global Sulfonylureas Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Meglitinides Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Alpha-glucosidase inhibitors Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Hospitals Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Clinics Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Others Consumption Forecast and Growth Rate (2022-2028)
-
Table Global Oral Antidiabetic Drugs Import by Region (Top 5 Countries) (2017-2028)
-
Table Global Oral Antidiabetic Drugs Export by Region (Top 5 Countries) (2017-2028)
-
Table Merck (Foundation Year, Company Profile and etc.)
-
Table Merck Oral Antidiabetic Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Merck Oral Antidiabetic Drugs Product and Service
-
Table Novartis (Foundation Year, Company Profile and etc.)
-
Table Novartis Oral Antidiabetic Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Novartis Oral Antidiabetic Drugs Product and Service
-
Table Eli Lilly (Foundation Year, Company Profile and etc.)
-
Table Eli Lilly Oral Antidiabetic Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Eli Lilly Oral Antidiabetic Drugs Product and Service
-
Table Sunpharma (Foundation Year, Company Profile and etc.)
-
Table Sunpharma Oral Antidiabetic Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Sunpharma Oral Antidiabetic Drugs Product and Service
-
Table Novo Nordisk (Foundation Year, Company Profile and etc.)
-
Table Novo Nordisk Oral Antidiabetic Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Novo Nordisk Oral Antidiabetic Drugs Product and Service
-
Table Biocon (Foundation Year, Company Profile and etc.)
-
Table Biocon Oral Antidiabetic Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Biocon Oral Antidiabetic Drugs Product and Service
-
Table Pfizer (Foundation Year, Company Profile and etc.)
-
Table Pfizer Oral Antidiabetic Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Pfizer Oral Antidiabetic Drugs Product and Service
-
Table Abbott (Foundation Year, Company Profile and etc.)
-
Table Abbott Oral Antidiabetic Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Abbott Oral Antidiabetic Drugs Product and Service
-
Table Sanofi (Foundation Year, Company Profile and etc.)
-
Table Sanofi Oral Antidiabetic Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Sanofi Oral Antidiabetic Drugs Product and Service
-
